Monday, September 25, 2017

In A First, Pfizer Spins Out Biotech Firm With $103 Million In Funding

Pfizer is announcing today that it is spinning out a new company, SpringWorks Therapeutics, to develop several drugs for rare diseases that the drug giant did not want to move forward internally.

from Forbes Real Time https://www.forbes.com/sites/elliekincaid/2017/09/25/in-a-first-pfizer-spins-out-biotech-firm-with-103-million-in-funding/
via IFTTT

No comments:

Post a Comment